ATG:biosynthetics GmbH

06/07/2022

ATG:biosynthetics CodoNewsletter #113 linked here is intended to draw your attention to , and encoded living functionality mediated by the in silico DNA-sequence evolution based software EvoMAG-V2.0 bioinformatics services covering the requirements and needs of the synthetic biology of .

ATG is known for fast, reliable and economical solutions.
https://www.atg-biosynthetics.com/NL/22062022CodoNews113/CodoNewsLetter%20113.html

05/12/2019

tANCHOR protein display vectors are specifically designed for the anchored extracellular presentation of the proteins. tANCHOR allows the conservation of the functional and structural integrity of the targets or antigens. Structural integrity and glycosylation has a significant positive impact on the quality of your results.
https://www.atg-biosynthetics.com/NL/191119CodoNews98/CodoNewsLetter98.html

• An important application of tANCHOR is its potential for the development of vaccines. Epitopes are exposed on the surface and can be used to immunize animals with desired epitops. • For a direct DNA – immunization approach in which tANCHOR vector is tranfected into muscle tissue via a GeneGu...

10/07/2019

Synthetic biology engineering means functionally designing biochemical and signal pathways as well as hetero-protein complex formation on the level of gene-clusters. This kind of molecular engineering can only be achieved by use of synthetic genes.

https://www.atg-biosynthetics.com/NL/NL190511CodoNews95/CodoNewsLetter95.html

Synthetic bioinformatics skills to analyze promoters and select the most powerful ones, or balancing expression between genes - see EvoMag and Optimizations Gene synthesis to realize any design and to generate complete multi-gene cassettes Multi-gene construction systems, e.g. our various FlexTEC or...

10/07/2019

ATG‘s tANCHOR PDF protein display technology is a demonstrated efficient solution for displaying antigenic determinants on mammalian cell surfaces. The antigens and epitopes used might be encoded by synthetic genes.

These can be generated as synthetic IMMUNOGENS from digital sources of immunogenomic and -genetic molecular information.

Thus the tANCHOR technology enables you to design and realize your own in vivo and in vitro immune assays.

https://www.atg-biosynthetics.com/NL/NL190619CodoNews96/CodoNewsLetter96.html

tANCHOR technology provides an innovative tool for displaying epitopes on the surface of human cells. This enables you to improve your ELISA methods to search for antibodies binding studies under native conditions on your target. An important application of tANCHOR is its potential for the developme...

29/05/2019

tANCHOR mammalian Peptide Display System meets PepID technology

ATG’s FlexTEC- Expression Technology Platform is designed especially for synthetic genes expressing one to multiple genetic units in one construct

https://www.atg-biosynthetics.com/NL/NL190515CodoNews94/CodoNewsLetter94.html

The tANCHOR provides an innovative and versatile tool for displaying poly-peptides like epitopes on the surface of e.g. human cells. tANCHOR is based on the use of tetraspanin surface trans-membrane anchors. These are derived from a âbundle of 4 tetraspanin trans-membrane domains assembled as a typ...

24/04/2019

Rational Content Based Quantitative Synthetic Biology and Synthetic Genes
https://www.atg-biosynthetics.com/NL/NL190305CodoNews93/CodoNewsLetter93.html

16/04/2019

ATG is a synthetic biology and biotechnology company. We offer straightforward gene synthesis, gene optimization and expression systems but are specifically experts for synthetic bioinformatics that enable complex combinatorial gene designs, multi-gene expression strategies and projects involving gene cluster design.
We offer bioinformatics and wet-lab expertise, products and services. Our mainstays are multi-gene and multi-peptide expression products and services along with bioinformatics analysis and work-up for academic and industrial R&D in the fields of drug discovery, industrial and medical biotechnology, molecular diagnostics, and bioengineering.
ATG is also looking for strategic partnerships and outsourcing projects that aim at developing and marketing high-potential applications, e.g. DNA- and protein based vaccines.